Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomas.
about
Clinical advances in molecular biomarkers for cancer diagnosis and therapyTRIM29 as a novel biomarker in pancreatic adenocarcinoma.Aberrant methylation patterns in cancer: a clinical view.Contemporary proteomic strategies for clinical epigenetic research and potential impact for the clinic.Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma.
P2860
Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomas.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Potential epigenetic biomarker ...... reatic ductal adenocarcinomas.
@en
type
label
Potential epigenetic biomarker ...... reatic ductal adenocarcinomas.
@en
prefLabel
Potential epigenetic biomarker ...... reatic ductal adenocarcinomas.
@en
P2093
P2860
P356
P1476
Potential epigenetic biomarker ...... reatic ductal adenocarcinomas.
@en
P2093
Charlie Bodine
Jesse Hinton
Jinping Li
Richard Callan
Shi-Wen Jiang
Steve Brower
Wayne Glasgow
P2860
P304
P356
10.1586/ERM.13.38
P577
2013-06-01T00:00:00Z